Author

Thomas Sarkodie

OpenAlex ID: A5033805146

Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma

2024 · Peter W. Szlosarek, Benjamin C. Creelan, et al. · JAMA Oncology · 60

Abstract CT007: Phase 2-3 trial of pegargiminase plus chemotherapy versus placebo plus chemotherapy in patients with non-epithelioid pleural mesothelioma

2023 · Peter W. Szlosarek, Ben Creelan, et al. · Cancer Research · 8

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5

104 Hemi-thoracic irradiation with proton therapy in malignant pleural mesothelioma (HIT-Meso)

2026 · Crispin Hiley, Andrew Gosling, et al. · Lung Cancer

Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)

2023 · Mohammad Islam, Abby Cyriac, et al. · Lung Cancer

Works count: 5

Citation count: 73

H-index: 3

I10-index: 1